|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
25,187,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
70,100 |
Avg
Vol: |
32,220 |
| 52
Week Range: |
$0.0041 - $0.0041 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barlow David S |
10% Owner |
– – • |
2011-01-28 |
4 |
S |
$0.14 |
$9,570 |
D/D |
(59,000) |
2,361,377 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2011-01-27 |
4 |
S |
$0.17 |
$6,510 |
D/D |
(38,000) |
2,420,377 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2010-12-17 |
4 |
S |
$0.19 |
$30,710 |
D/D |
(155,000) |
2,458,377 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2010-12-16 |
4 |
S |
$0.21 |
$9,680 |
D/D |
(45,000) |
2,613,377 |
|
- |
|
| Quintessence Fund L.p. |
|
– – – |
2010-06-27 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
364,581 |
|
- |
|
| Qvt Fund Lp |
|
– – – |
2010-06-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
364,581 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2010-01-14 |
4 |
S |
$1.95 |
$11,566 |
D/D |
(5,800) |
2,658,377 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2010-01-12 |
4 |
S |
$2.06 |
$8,313 |
D/D |
(4,000) |
2,664,177 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2009-12-24 |
4/A |
S |
$2.34 |
$5,850 |
D/D |
(2,500) |
2,668,177 |
|
- |
|
| Barlow David S |
Director |
– • • |
2009-12-24 |
4 |
S |
$2.34 |
$4,680 |
D/D |
(2,000) |
2,668,677 |
|
- |
|
| Barlow David S |
10% Owner |
– – • |
2009-12-23 |
4/A |
S |
$2.31 |
$28,319 |
D/D |
(12,000) |
2,670,677 |
|
- |
|
| Barlow David S |
Director |
– • • |
2009-12-23 |
4 |
S |
$2.31 |
$31,909 |
D/D |
(13,500) |
2,668,177 |
|
- |
|
| Barlow David S |
Director |
– • • |
2009-12-21 |
4 |
S |
$2.30 |
$14,718 |
D/D |
(6,300) |
2,683,677 |
|
- |
|
| Barlow David S |
Director |
– • • |
2009-12-18 |
4 |
S |
$2.24 |
$12,400 |
D/D |
(5,500) |
2,689,977 |
|
- |
|
| Frank Daniel |
Director |
– • – |
2009-10-06 |
5 |
A |
$0.00 |
$0 |
D/D |
3,679 |
146,959 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-28 |
5 |
OE |
$3.93 |
$53,055 |
D/D |
13,500 |
37,500 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-25 |
5 |
OE |
$3.93 |
$15,720 |
D/D |
4,000 |
24,000 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-24 |
5 |
OE |
$3.93 |
$15,720 |
D/D |
4,000 |
20,000 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-23 |
5 |
OE |
$3.93 |
$15,720 |
D/D |
4,000 |
16,000 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-22 |
5 |
OE |
$3.93 |
$15,720 |
D/D |
4,000 |
12,000 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-09-18 |
5 |
OE |
$3.93 |
$31,440 |
D/D |
8,000 |
8,000 |
|
- |
|
| Wallroth Donald E. |
Former Chief Financial Officer |
– – – |
2009-08-22 |
5 |
D |
$0.00 |
$0 |
D/D |
(13,500) |
0 |
|
- |
|
| Gottlieb Scott |
Director |
– • – |
2009-05-29 |
4 |
B |
$3.83 |
$15,320 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| Lafrance Norman D. |
Sr. VP Clinical Dev and CMO |
• – – |
2009-05-28 |
4 |
S |
$3.76 |
$22,910 |
D/D |
(6,093) |
16,657 |
|
- |
|
| Wallroth Donald E. |
Officer |
– – – |
2009-05-26 |
144 |
NP |
$0.00 |
$24,960 |
/ |
6,500 |
0 |
|
- |
|
74 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
